The packaging image may vary depending on the country in which it is marketed.
Manufacturer
CZ Vaccines, S.A.U
Medicinal product subject to veterinary prescription
For futher information, please see the Summary of Product Characteristics (SPC)
HEPIZOVAC
Injectable suspension against Epizootic haemorrhagic disease virus (EHDV), serotype 8
Target species
Cattle
Composition
Active substances:
Adjuvants:
Epizootic haemorrhagic disease virus (EHDV), serotype 8,
strain EHDV8 SPA 2022/LCV_03 LCV Cod.:O78, inactivated 105.5DICC50 *
*CCID50: 50% cell culture infective dose equivalent to titre prior inactivation.
Adjuvants:
Aluminium hydroxide 6 mg
Purified saponin (Quil A) 0,05 mg
Indications
For the active immunisation of cattle to prevent viraemia caused by serotype 8 of the epizootic haemorrhagic disease virus.
Route of administration
Subcutaneous use
Dosage
4 ml
Vaccination schedule:
- Primary vaccination
- From 2 months of age. Administer two doses of 4 mL subcutaneously 3 weeks apart.
- Revaccination
- Not established.
Withdrawal period
Zero days
Presentation
Container: bottle (HDPE), Package size: 1 bottle, Contents may include: 100 ml, 252 ml, 52 ml.